Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib
Corresponding Author
Nika Finelt M.D.
Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York
Address correspondence to Nika Finelt, M.D., Department of Dermatology, Hofstra Northwell School of Medicine, 1991 Marcus Avenue, Suite 300, New Hyde Park, NY 11042, or e-mail: [email protected].Search for more papers by this authorRishi R. Lulla M.D., M.S.
Division of Pediatric Hematology, Oncology, Neuro-Oncology and Stem Cell Transplant, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois
Search for more papers by this authorHector Melin-Aldana M.D.
Division of Pathology, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois
Search for more papers by this authorJennifer Shuley Ruth M.D.
Division of Dermatology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorFrank Y. Lin M.D.
Division of Pediatric Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorJack M. Su M.D.
Division of Pediatric Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorCrystal Y. Pourciau M.D., M.P.H.
Division of Dermatology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorRaegan D. Hunt M.D., Ph.D.
Division of Dermatology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorBrandi M. Kenner-Bell M.D.
Division of Dermatology, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois
Search for more papers by this authorCorresponding Author
Nika Finelt M.D.
Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York
Address correspondence to Nika Finelt, M.D., Department of Dermatology, Hofstra Northwell School of Medicine, 1991 Marcus Avenue, Suite 300, New Hyde Park, NY 11042, or e-mail: [email protected].Search for more papers by this authorRishi R. Lulla M.D., M.S.
Division of Pediatric Hematology, Oncology, Neuro-Oncology and Stem Cell Transplant, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois
Search for more papers by this authorHector Melin-Aldana M.D.
Division of Pathology, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois
Search for more papers by this authorJennifer Shuley Ruth M.D.
Division of Dermatology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorFrank Y. Lin M.D.
Division of Pediatric Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorJack M. Su M.D.
Division of Pediatric Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorCrystal Y. Pourciau M.D., M.P.H.
Division of Dermatology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorRaegan D. Hunt M.D., Ph.D.
Division of Dermatology, Texas Children's Cancer Center, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas
Search for more papers by this authorBrandi M. Kenner-Bell M.D.
Division of Dermatology, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois
Search for more papers by this authorAbstract
Vemurafenib is increasingly being used to treat nonmelanoma tumors that are positive for the BRAF V600E mutation. We report three children who presented with panniculitis induced by vemurafenib while undergoing treatment for central nervous system tumors and review the literature.
References
- 1Bollag G, Hirth P, Tsai J et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 2010; 467: 596–599.
- 2Schindler G, Capper D, Meyer J et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011; 121: 397–405.
- 3Robinson GW, Orr BA, Gajjar A. Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. BMC Cancer 2014; 14: 258.
- 4Rush S, Foreman N, Liu A. Brainstem ganglioglioma successfully treated with vemurafenib. J Clin Oncol 2013; 31: e159–e160.
- 5Skrypek M, Foreman N, Guillaume D et al. Pilomyxoid astrocytoma treated successfully with vemurafenib. Pediatr Blood Cancer 2014; 61: 2099–2100.
- 6Del Bufalo F, Carai A, Figa-Talamanca L et al. Response of recurrent BRAFV600E mutated ganglioglioma to vemurafenib as single agent. J Transl Med 2014; 12: 356.
- 7Bautista F, Paci A, Minard-Colin V et al. Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas. Pediatr Blood Cancer 2014; 61: 1101–1103.
- 8West ES, Williams VL, Morelli JG. Vemurafenib-induced neutrophilic panniculitis in a child with a brainstem glioma. Pediatr Dermatol 2015; 32: 153–154.
- 9 Zelboraf [package insert]. Genentech USA, San Francisco, CA; November 2014. http://www.gene.com/download/pdf/zelboraf_prescribing.pdf (accessed on March 31, 2015).
- 10Mossner R, Zimmer L, Berking C et al. Erythema nodosum-like lesions during BRAF inhibitor therapy: report on 16 new cases and review of the literature. J Eur Acad Dermatol Venereol 2015; 29: 1797–1806.
- 11Choy B, Chou S, Anforth R et al. Panniculitis in patients treated with BRAF inhibitors: a case series. Am J Dermatopathol 2014; 36: 493–497.
Citing Literature
